Skip to main navigation Skip to search Skip to main content

HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor

  • Natalya M. Kogan
  • , Michael Schlesinger
  • , Esther Priel
  • , Ruth Rabinowitz
  • , Eduard Berenshtein
  • , Mordechai Chevion
  • , Raphael Mechoulam

Research output: Contribution to journal › Article › peer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science